Close Menu

NEW YORK (GenomeWeb) – Oncgnostics, a Jena, Germany-based molecular diagnostic company, has out-licensed its GynTect cervical cancer test to Changchun Jienuo Medical Technology (CJMT), a subsidiary of Sinopharm Group in China.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Sponsored by
Sysmex Inostics

This webinar will present recent evidence that demonstrates how incorporating circulating tumor DNA (ctDNA) assessments into real-world patient management can influence patient care decisions, alter radiographic interpretations, and impact clinical outcomes.


This webinar will outline the entire liquid biopsy workflow from cell-free DNA isolation to mutation detection by Crystal Digital PCR with the Naica System from Stilla Technologies.